Peripartum cardiomyopathy (PPCM) is a specific cardiomyopathy in which heart failure develops due to reduced myocardial contraction during pregnancy or in the postpartum period in women without a previous history of heart disease. The epidemiology of PPCM has been reported in various countries and areas, and the incidence of PPCM differed among these reports. The incidence was highest (1 in 102 deliveries) in Nigeria and lowest (1 in 15,533 births) in Japan. The incidence was higher in African-Americans than in other races in several reports from the United States, and was also high in African countries and Haiti, indicating that the risk for PPCM is highest in the black race. However, the study design and definition of PPCM differ among studies, and these differences may influence the incidence. Moreover, the incidence of PPCM and the maternal mortality rate were well correlated. Since maternal mortality reflects the level of perinatal health care and hygiene, this finding suggests that the extent of perinatal care is partly related to the incidence of PPCM, which reflects heart failure and cardiomyopathy of unknown cause in women.
P eripartum cardiomyopathy (PPCM) causes unexplained left ventricular systolic dysfunction and heart failure towards the end of pregnancy or in the months following delivery in previously healthy women.
1) The pathogenesis is still unclear. PPCM is a diagnosis of exclusion, which may indicate that it is a group of heterogeneous conditions. The epidemiology of PPCM has been examined in various countries and areas, and several risk factors, such as advanced maternal age, hypertensive disorders in pregnancy (HDP) and multiple conceptions, have been identified. 2, 3) In addition, genetic analysis has shown that some cases of PPCM and dilated cardiomyopathy share a genetic background. 4) Interestingly, the prevalence of risk factors including HDP, 5) outcomes of patients treated at a similar health care level, 6) and genetic background 4) are similar among countries, suggesting that although PPCM is a heterogeneous disease, it has similar clinical features worldwide. In contrast, the incidence of PPCM markedly varies among countries and areas. 7) Racial differences are the clearest explanation of these differences, but no detailed review of the incidence of PPCM by country and area or investigation of factors other than race has been performed. In this review, we summarize previous reports on the incidence of PPCM and discuss the possible causes of differences among these reports.
Worldwide Incidence of PPCM
To investigate the worldwide incidence of PPCM, we searched English literature relevant to PPCM on PubMed from inception to April 2018 using the following search terms: "peripartum cardiomyopathy" or "pregnancyassociated cardiomyopathy". To ensure a comprehensive search of the literature, we also manually searched the reference lists of the included studies and published reviews. Next, we identified 31 studies that reported the incidence of PPCM. The incidences of PPCM and patient characteristics are summarized in Table I . The study design and diagnostic criteria of PPCM of each study are summarized in Table II . Incidences with 95% confidence intervals were calculated using the Clopper-Pearson (exact) method for a binomial proportion. 8) Many studies have been reported from the United States, [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] but the only study in Japan is that by Kamiya, et al. 3) Several studies have been conducted in other Asian countries, [21] [22] [23] [24] [25] [26] but all were single-center studies, except for use of national administrative data in Korea 27) and Taiwan. 28) In Europe, an inter-ISOGAI, ET AL The unit of population differed among studies as the following symbols indicate: * for births, † for live births, ‡ for deliveries, § for pregnancy/delivery hospitalizations, and || for delivering women.
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Incidences with 95% CI were calculated using the Clopper-Pearson (exact) method for a binomial proportion. 8 29, 30) but only studies in Denmark and Sweden have reported the incidence of PPCM. 31, 32) Fewer studies have been conducted in Central America, 33, 34) the Middle East, 35) Africa, [36] [37] [38] [39] and to our knowledge, there are no English reports on the incidence of PPCM in South America. Most studies were performed in the 1990s to 2000s, with fewer reports after 2010. The mean age of patients with PPCM ranged from 27 to 33 years old, and the mean left ventricular ejection fraction was 24 to 35%.
The incidence of PPCM varies markedly among countries, areas, and races. The highest incidence of 1 in 102 deliveries was found in Nigeria 36) and the lowest incidence was 1 in about 15,000 births in Japan 3) (the incidence in Japan was recalculated for this review, as described below). In studies conducted in the United States, the incidence among African-Americans is the highest, at 1 in 439 to 1,421 deliveries, 9, 15) and the relative risk for PPCM in African-Americans is approximately 16 times that in other races. 40) The high risk in blacks is also shown by the high incidence (1 in 100 to 1,000 deliveries) in studies in African countries 36, 38, 39) and Haiti, 34) in which the subjects were mostly black. However, it is unclear whether this high incidence is due to genetic background [41] [42] [43] [44] or to lifestyle, culture, socioeconomics, 36, [45] [46] [47] and/or accompanying pregnancy-related complications. There are no consistent results for the risk of PPCM in Caucasians, Asians, and Hispanics in studies conducted in the United States. 9, 15) Based on the temporal trend analyses of several large-scale administrative datasets, the number of patients with PPCM tends to be higher in developed countries. 9, 13, 28, 32) This may partly be due to the older age of pregnant women and higher prevalence of pregnancyrelated complications than the past and changes in the maternal background, such as an increase in multiple pregnancy cases associated with the spread of reproductive medicine. Improved recognition of PPCM by health professionals also may have led to an increase in the number of PPCM diagnoses. In addition, the definition of the onset time period of heart failure in diagnostic criteria has recently been expanded. Previously, PPCM was defined as heart failure that developed 'in the last month of pregnancy or within 5 months of delivery', 48) but the onset time period is now defined as 'toward the end of pregnancy to several months after delivery' in diagnostic criteria established in 2010 by the Heart Failure Association of the European Society of Cardiology. 49) In reports from Japan, the United States, and Taiwan, heart failure was newly diagnosed during pregnancy more than 1 month before delivery and 5 months after delivery or later. 3, 28, 50) This suggests that the number of diagnoses may increase due to expansion of the onset time period in diagnostic criteria.
Incidence of PPCM in Japan
Kamiya, et al. 3) performed a nationwide questionnaire survey of institutions throughout Japan in 2009, which is the only study reporting the incidence of PPCM in Japan. Only ICD-coded diagnoses (ICD-9-CM or ICD-10) for administrative claims without medical chart reviews were used to identify PPCM cases. PPCM indicates peripartum cardiomyopathy; EF, ejection fraction; FS, fractional shortening; NA, not available; and ICD, International Classification of Diseases. In this survey, a questionnaire was sent to 1,444 institutions with departments of cardiology or obstetrics, or an emergency department, and responses were received from 1,049 institutions (response rate: 72.6%), in which 102 patients were diagnosed with PPCM in 2007-2008. The mean age of these 102 patients was 32.7 years old, and 15% had twin pregnancy, 38% had HDP, 14% received tocolytic therapy during pregnancy, and 33% were diagnosed with PPCM at the time of delivery to within 1 week after delivery. Kamiya, et al. 3) estimated the incidence of PPCM in Japan to be about 1 in 20,000 births based on the 102 PPCM patients and the total number of births in the Vital Statistics reported by the Ministry of Health, Labour and Welfare. 51) However, since the rate of response to the questionnaire was 72.6%, the 102 cases of PPCM may not accurately represent the total number of cases in 2007-2008 in Japan. Thus, in this review, assuming that the incidence of PPCM in the 295 institutions that did not respond to the questionnaire was the same as that in the 1,049 responder institutions, the total number of PPCM cases in 2007-2008 was estimated to be 140 (102 1,444/1,049 ! 140). Since the total number of births in 2007-2008 was 2,180,974, 51) the incidence of PPCM in Japan was estimated to be 1 in 15,533 births. It should be noted that this incidence (1 in 15,533 births) and the incidence (1 in 20,000 births) reported by Kamiya, et al. 3) are both rough estimates.
ISOGAI, ET AL
In the PPCM diagnostic criteria of the survey, 3) the onset time for heart failure included the entire pregnancy period and left ventricular systolic dysfunction was defined as an ejection fraction < 50%. These were less strict criteria compared with other studies. Nevertheless, the estimated incidence in Japan was the lowest worldwide. This may be due to epidemiological factors such as the racial and genetic background of the Japanese population, lifestyle, a decrease in women giving birth multiple times, and influence of the health care system. However, the incidence is far lower than those found in administrative data in Korea (1 in 1,741 deliveries) 27) and Taiwan (1 in 4,725 deliveries) 28) that are also in East Asia, are mostly populated by Asians, and have health care systems similar to that in Japan. Thus, the study by Kamiya, et al. may have underestimated the incidence of PPCM due to biases related to the study design and the calculation used to estimate the incidence.
3) Further studies are needed to evaluate the incidence of PPCM in Japan.
The mortality rate due to PPCM was 3.9% in the Japanese survey, 3) which is comparable to those in recent reports from Europe and the United States. 29, 31, 52) In an analysis of the maternal deaths registry of the Japan Association of Obstetricians and Gynecologists, 53) PPCM was the cause of death in 3 of 15 mothers who died from cardiovascular disease in 2010-2012 in Japan. These data show that PPCM is a life-threatening maternal cardiovascular event in the peripartum period.
Difficulties with Studies of the Incidence of PPCM
In the studies shown in Tables I and II , there are several difficulties with regard to accurate determination of the incidence of PPCM and comparisons among studies. First, only 4 single-center studies were prospective, 18, 34, 36, 38) while all others were performed retrospectively. Second, from the perspective of data sampling, studies using administrative databases from the United States, [9] [10] [11] [12] [13] [14] [15] [16] [17] Canada, 54) Denmark, 31) Sweden, 32) Korea, 27) and Taiwan 28) were based on population-based cohort data, but cases of PPCM were screened and identified using diagnoses recorded with the International Classification of Diseases codes for hospital payments. Generally, diagnoses based on the codes in administrative databases are not confirmed by medical chart reviews and thus are less accurate and less validated than diagnoses in prospective studies, which can lead to misdiagnosis and over-or underestimation of the incidence. Third, diagnostic criteria have differed among studies. Therefore, a prospective population-based cohort study that uses consensus diagnostic criteria is required to determine an accurate incidence. However, given the rarity of PPCM, conducting such a prospective study is not easy and will be labor-intensive and costly. Moreover, the pathogenesis of PPCM remains unclear, which fundamentally makes investigation of the incidence of PPCM difficult. PPCM is still a diagnosis of exclusion due to the absence of a specific diagnostic method. Thus, although a large-scale prospective cohort study is desirable, it may be a practical approach to investigate the incidence of PPCM over time based on population-based data in a similar way to administrative database studies in other countries.
Overall Maternal Mortality and PPCM
The maternal mortality rate reflects the level of maternal health care. The United Nations Maternal Mortality Estimation Inter-Agency Group reported the global, regional and national levels of maternal mortality from 1990 to 2015. 55) Globally, the maternal mortality rate fell by nearly 44% over the past 25 years, but is still high in developing regions. In particular, sub-Saharan Africa alone accounts for approximately 66% of global maternal deaths, followed by Southern Asia. At the nation level, 3 countries outside the sub-Saharan African region have particularly high maternal mortality: Afghanistan, Yemen and Haiti. These regions and nations with high maternal mortality are also known to have a high incidence of PPCM. The maternal mortality rates 56) and incidences of PPCM in 15 countries are shown in the Figure. The maternal mortality and incidence of PPCM were well correlated (Spearman ρ 0.80, P < 0.001). PPCM is a major cause of maternal death and is directly related to an increase in maternal mortality. Thus, the correlation between these two rates may be considered natural. However, in developing countries, many cases of maternal death are directly caused by obstetric complications such as infection and hemorrhage, while the mortality rate from PPCM in developed countries is relatively low at 2-8% (4% in Japan). 3, 57, 58) Considering that pregnancy-related complications such as HDP and multiple pregnancy are major risk factors for PPCM, it is possible that the level of maternal health care, including perinatal care for obstetrical complications, is associated with the incidence of PPCM. Although multiple par-
INCIDENCE OF PERIPARTUM CARDIOMYOPATHY

Figure.
Maternal mortality rate and incidence of PPCM in various countries. PPCM indicates peripartum cariomyopathy. *The unit of population differs among studies depending on the population representing all births, live births (excluding stillbirth), deliveries, hospitalizations, and women. †Although there are several reports from the United States, the report by Kolte, et al. 9) was selected because it includes the most recent data.
ity is known as a risk factor for PPCM, in countries with a declining birth rate, such as Japan, the number of primiparas with PPCM is larger than that of multiparas and multiple parity is not found to be a risk factor. Meanwhile, in areas with a low level of maternal health care, contraception and family planning have not sufficiently spread and women tend to deliver multiple times. These epidemiological factors may indirectly contribute to the high incidence of PPCM in countries and areas with high maternal mortality. The health care level of women may be related to the development of heart failure of unknown cause in pregnant women. Therefore, improving the quality of maternal health care may lead to a decrease in the incidence of PPCM in areas with limited maternal health care. Meanwhile, increases in the age of pregnant women and accompanying pregnancy-related complications and multiple parity due to widespread use of reproductive medicine are likely to increase the incidence of PPCM in developed countries. 7) Thus, improving maternal health care alone may not be sufficient to reduce cases of PPCM in developed countries.
Conclusion
The incidence of PPCM markedly varies among countries and areas. Race is one cause of these differences, and previous studies suggest that being black is a major risk factor for PPCM. However, differences in the study design and definition of PPCM among reports may have influenced the incidence. Furthermore, the incidence of PPCM and the maternal mortality rate were well correlated. The level of perinatal care may partly affect the incidence of PPCM.
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